PI
NVO

PFG Investments’s Novo Nordisk NVO Stock Holding History

PFG Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Sell
15,644
-1,163
-7% -$50K 0.03% 501
2026
Q1 		$618K Sell
16,807
-4,859
-22% -$230K 0.03% 525
2025
Q4 		$1.1M Buy
21,666
+7,973
+58% +$408K 0.05% 321
2025
Q3 		$760K Sell
13,693
-9,268
-40% -$542K 0.04% 415
2025
Q2 		$1.58M Buy
22,961
+4,859
+27% +$331K 0.09% 203
2025
Q1 		$1.26M Buy
18,102
+178
+1% +$14.7K 0.08% 242
2024
Q4 		$1.54M Buy
17,924
+1,389
+8% +$150K 0.1% 202
2024
Q3 		$1.97M Buy
16,535
+72
+0.4% +$9.6K 0.13% 159
2024
Q2 		$2.35M Sell
16,463
-14,745
-47% -$1.95M 0.17% 114
2024
Q1 		$4.01M Buy
31,208
+17,065
+121% +$2.03M 0.24% 84
2023
Q4 		$1.46M Buy
14,143
+469
+3% +$46.4K 0.27% 78
2023
Q3 		$1.24M Buy
13,674
+314
+2% +$27.7K 0.23% 83
2023
Q2 		$1.08M Sell
13,360
-460
-3% -$37.6K 0.19% 118
2023
Q1 		$1.1M Buy
+13,820
New +$980K 0.22% 98

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

PFG Investments's NVO Position: Q2 2026 in Review

PFG Investments reduced its Novo Nordisk (NVO) stake by 6.9% in Q2 2026, selling an estimated $50K and leaving 15,644 shares worth $750K. The position accounts for 0.03% of the portfolio, ranked #501.

PFG Investments first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.01M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • PFG Investments held 15,644 shares of Novo Nordisk worth $750K as of Q2 2026.
  • PFG Investments sold 1,163 Novo Nordisk shares in Q2 2026, an estimated $50K.
  • Novo Nordisk made up 0.03% of PFG Investments's portfolio in Q2 2026, its #501 holding.
  • PFG Investments first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • PFG Investments's Novo Nordisk position peaked at $4.01M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.